Persistent Asset Partners’s iTeos Therapeutics ITOS Stock Holding History

Persistent Asset Partners’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-47,512	Closed	-$474K	–	271
2025 Q2	$474K	Buy	+47,512	New	+$383K	0.35%	81

Other funds holding ITOS

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Persistent Asset Partners's ITOS Position: Q3 2025 in Review

Persistent Asset Partners sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 47,512 shares — an estimated $474K sold.

Persistent Asset Partners first reported a position in ITOS in Q2 2025 and held it in 1 quarter. The position peaked at $474K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

Persistent Asset Partners reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
Persistent Asset Partners sold 47,512 iTeos Therapeutics shares in Q3 2025, an estimated $474K.
Persistent Asset Partners first reported a position in iTeos Therapeutics in Q2 2025 and held it in 1 quarter.
Persistent Asset Partners's iTeos Therapeutics position peaked at $474K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.